Original Article

CME Article: Association between Gastroparesis and Rheumatoid Arthritis: A US Population–Based Study

Authors: Saad Saleem, MD, Zahid Ijaz Tarar, MD, Waseem Amjad, MD, Adnan Malik, MD, Rizwan Ishtiaq, MD, Thomas L. Abell, MD

Abstract

Objectives: Patients with rheumatoid arthritis (RA) have a high prevalence of nausea, vomiting, postprandial fullness, and abdominal pain; these are symptoms that are similar to those in gastroparesis (GP). The aim of this study was to assess the association between GP and RA and the determinants of GP.

Methods: We identified patients with RA and patients with GP from the 2012–2014 National Inpatient Sample database. The t test and the χ2 test were used for continuous and categorical variables, respectively. We determined the association between RA and GP and independent predictors of GP by multivariate analysis.

Results: Of 1,514,960 patients with RA, there were 1070 hospitalizations in which a primary diagnosis of GP was identified. The GP odds ratio in RA was found to be 1.36 and the 95% confidence interval was 1.24 to 1.49 (P < 0.0001). The variables increasing the odds of GP were age intervals of 18 to 35 years, 36 to 50 years, and 51 to 65 years; being female, White, or Black; a median household income in the 26th to 50th and the 51st to 75th percentiles; having diabetes mellitus; and having RA.

Conclusions: An increased likelihood of 36% of GP among patients with RA was determined. White and Black patients younger than age 65 showed a greater risk of developing GP.
Posted in: Gastroenterology53 Rheumatology and Orthopedics24

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Saleem S, Inayat F, Aziz M, et al. In-hospital mortality in gastroparesis population and its predictors: a United States-based population study. JGH Open 2021;5:350–355.
 
2. Soykan I, Sivri B, Sarosiek I, et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci 1998;43:2398–2404.
 
3. Rao JN. Estrogens and gastroparesis: a clinical relevance. Dig Dis Sci 2013; 58:1449–1451.
 
4. Myasoedova E, Crowson CS, Kremers HM, et al. Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955–2007. Arthritis Rheum 2010;62:1576–1582.
 
5. Eriksson JK, Neovius M, Ernestam S, et al. Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration. Arthritis Care Res (Hoboken) 2013;65:870–878.
.
6. Birnbaum H, Pike C, Kaufman R, et al. Societal cost of rheumatoid arthritis patients in the US. Curr Med Res Opin 2010;26:77–90.
 
7. Louati K, Berenbaum F. Fatigue in chronic inflammation—a link to pain pathways. Arthritis Res Ther 2015;17:254.
 
8. Stebbings S, Treharne GJ. Fatigue in rheumatic disease: an overview. Int J Clin Rheumtol 2010;5:487–502.
 
9. Nikolaus S, Bode C, Taal E, et al. Fatigue and factors related to fatigue in rheumatoid arthritis: a systematic review. Arthritis Care Res (Hoboken) 2013;65:1128–1146.
 
10. Myasoedova E, Talley NJ, Manek NJ, et al. Prevalence and risk factors of gastrointestinal disorders in patients with rheumatoid arthritis: results from a population-based survey in Olmsted County Minnesota. Gastroenterol Res Pract 2011;2011:745829.
 
11. Craig E, Cappelli LC. Gastrointestinal and hepatic disease in rheumatoid arthritis. Rheum Dis Clin North Am 2018;44:89–111.
 
12. Agency for Healthcare Research and Quality. NIS description of data elements. https://hcup-us.ahrq.gov/db/nation/nis/nisdde.jsp. Accessed March 7, 2023.
 
13. Edmonds ME, Jones TC, Saunders WA, et al. Autonomic neuropathy in rheumatoid arthritis. Br Med J 1979;2:173.
 
14. Geenen R, Godaert GL, Jacobs JW, et al. Diminished autonomic nervous system responsiveness in rheumatoid arthritis of recent onset. J Rheumatol 1996;23:258–264.
 
15. Aggarwal D, Singla S. Prevalence of autonomic neuropathy in patients of rheumatoid arthritis and its correlation with disease severity. J Clin Diagn Res 2017;11:OC09.
 
16. Syngle V, Syngle A, Garg N, et al. Predictors of autonomic neuropathy in rheumatoid arthritis. Auton Neurosci 2016;201:54–59.
 
17. Nguyen L, Wilson LA, Miriel L, et al. Autonomic function in gastroparesis and chronic unexplained nausea and vomiting: relationship with etiology, gastric emptying, and symptom severity. Neurogastroenterol Motil 2020; 32:e13810.
 
18. Husby G. Amyloidosis and rheumatoid arthritis. Clin Exp Rheumatol 1985; 3:173–180.
 
19. Battle WM, Rubin MR, Cohen S, et al. Gastrointestinal-motility dysfunction in amyloidosis. N Engl J Med 1979;301:24–25.
 
20. Camilleri M, Malagelada JR, Stanghellini V, et al. Gastrointestinal motility disturbances in patients with orthostatic hypotension. Gastroenterology 1985;88:1852–1859.
 
21. Mohammad MK, Pepper DJ, Kedar A, et al. Measures of autonomic dysfunction in diabetic and idiopathic gastroparesis. Gastroenterol Res 2016; 9:65–69.
 
22. Abell T, Cardoso S, Schwartzbaum JA, et al. Diabetic gastroparesis is associated with an abnormality in sympathetic innervation. Eur J Gastroenterol Hepatol 1994;6:241–248.
 
23. Fich A, Neri M, Camilleri M, et al. Stasis syndromes following gastric surgery: clinical and motility features of 60 symptomatic patients. J Clin Gastroenterol 1990;12:505–512.
 
24. Grover M, Farrugia G, Lurken MS, et al. Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology 2011;140:1575–1585.e8.
 
25. Udalova IA, Mantovani A, Feldmann M. Macrophage heterogeneity in the context of rheumatoid arthritis. Nat Rev Rheumatol 2016;12:472–485.
 
26. Becker L, Nguyen L, Gill J, et al. Age-dependent shift in macrophage polarisation causes inflammation-mediated degeneration of enteric nervous system. Gut 2018;67:827–836.
 
27. Grover M, Gibbons SJ, Nair AA, et al. Transcriptomic signatures reveal immune dysregulation in human diabetic and idiopathic gastroparesis. BMC Med Genomics 2018;11:62.
 
28. Eisenman ST, Gibbons SJ, Verhulst PJ, et al. Tumor necrosis factor alpha derived from classically activated “M1” macrophages reduces interstitial cell of Cajal numbers. Neurogastroenterol Motil 2017;29:10.1111/nmo.12984.
 
29. Habtezion A, Wiley JW. Diabetic gastroparesis: an emerging role for macrophages and heme oxygenase-1. Gastroenterology 2010;138:2219–2223.
 
30. van Kerkhoven LA, Eikendal T, Laheij RJ, et al. Gastrointestinal symptoms are still common in a general Western population. Neth J Med 2008;66:18–22.
 
31. Sandler RS, Stewart WF, Liberman JN, et al. Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact. Dig Dis Sci 2000;45: 1166–1171.
 
32. Jung HK, Choung RS, Locke GR 3rd, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology 2009;136:1225–1233.
 
33. Grover M, Farrugia G, Lurken MS, et al. Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology 2011;140:1575–1585.
 
34. Oh JH, Pasricha PJ. Recent advances in the pathophysiology and treatment of gastroparesis. J Neurogastroenterol Motil 2013;19:18–24.
 
35. Parkman HP, Yates K, Hasler WL, et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology 2011;140:101–115.
 
36. Gangula PR, Sekhar K, Mukhopadhyay S. Gender bias in gastroparesis: is nitric oxide the answer? Dig Dis Sci 2011;56:2520–2527.
 
37. Parkman HP, Yates K, Hasler WL, et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology 2011;140:101–115.
 
38. Wallander MA, Johansson S, Ruigómez A, et al. Dyspepsia in general practice: incidence, risk factors, comorbidity and mortality. Fam Pract 2007;24: 403–111.
 
39. Talley NJ, Weaver AL, Zinsmeister AR. Smoking, alcohol, and nonsteroidal anti-inflammatory drugs in outpatients with functional dyspepsia and among dyspepsia subgroups. Am J Gastroenterol 1994;89:524–528.